Gustavo Tesolin appointed Regional Director of EW Nutrition LATAM

29 January 2024, Visbek – German-based company EW Nutrition, a global provider of functional animal nutrition solutions, has appointed Gustavo Carlos Tesolin as its Regional Director for Latin America.

An agricultural engineer by training, Gustavo Tesolin has forged an international career in the Animal Health business during the last 25 years. With different leadership roles in several major international organizations such as Novartis, Elanco, and Erber Group, Mr. Tesolin brings along important experience in Commercial Operations, P&L drive, and Strategy execution, with special emphasis on team development and geographic expansion.

“I am really excited to join a company as innovation-driven and science-focused as EW Nutrition,” Tesolin said. “The recent launch of VENTAR D, a novel phytogenic specifically designed and developed to improve animal husbandry results, will continue to strengthen our position in the region, together with our winning brands PRETECT D and ACTIVO” and added, “I am eager to take on the challenge and better acquaint the market with an excellent portfolio centered on Gut Health Management, Digestibility, and Feed Quality.”

Jan Vanbrabant, CEO of EW Nutrition, noted that Gustavo Tesolin is “the perfect combination of the right experience and the right attitude. We are happy to have found in him a proven leader with not just excellent market knowledge, but with the same values we share in EW Nutrition: a passion for innovation in the service of our customers, and relentless curiosity and energy to find the right solution.”

This appointment comes on the heels of several top-tier global hires over the last 18 months and reflects the company’s commitment to the Latin American market.

Tesolin will move to Mexico to coordinate EW Nutrition’s expansion in Latin American countries.

About EW Nutrition

EW Nutrition is a German-based international animal nutrition company that offers comprehensive solutions for animal gut health, toxin risk management, growth performance, and more.

Press contact

marketing@ew-nutrition.com

EW Nutrition welcomes Jan Vanbrabant as new CEO

VISBEK (Germany), 1 September 2023 — EW Nutrition, a leading global provider of functional animal nutrition solutions, welcomes Jan Vanbrabant as its new Chief Executive Officer.

Jan has a PhD degree in microbiology and is an experienced manager in animal health and nutrition, having held leadership roles at DSM, Erber Group, Biomin and Kemin.

“We are very pleased that we have found a strong management lead in Jan, who embodies the philosophy of EW Nutrition”, says Jan Wesjohann, Managing Director of parent company EW Group. “EW Nutrition is an innovation-driven company, with intensive investment in R&D. Together with Jan we are looking to enter the next growth phase of EW Nutrition.”

“I am very excited to be joining the EW Nutrition team,” said Jan Vanbrabant. “EW Nutrition’s long-term focus has created an extremely competitive portfolio. EW Nutrition is uniquely positioned to support its customers in mastering the challenges of the changing animal health and nutrition environment.”

Former CEO Michael Gerrits is heading into retirement after six years leading EW Nutrition. “I want to thank Michael Gerrits for his essential stewardship in bringing the company to the next level,” said Jan Wesjohann.

About EW Nutrition

EW Nutrition is a global animal nutrition company that offers integrators, feed companies, and veterinarians comprehensive solutions for animal gut health and performance, feed quality, digestibility, and more. It is focused on promoting sustainable growth through reduced FCR, natural support against challenges, reduced need for antibiotics, and planet-friendly protein production.

Contact:
Ilinca Anghelescu
marketing@ew-nutrition.com

EW Nutrition acquires Feed Quality and Pigment business from Novus International

VISBEK (February 1, 2021) – EW Nutrition has today completed the acquisition of the Feed Quality and Pigments business from Novus International, Inc. Under the terms of the agreement, EW Nutrition becomes the owner of world-renowned brands such as Santoquin® feed preservative, SURF●ACE®, a feed mill processing aid, and feed ingredient Agrado®. The acquisition also gives EW Nutrition ownership of a state-of-the-art production facility in Constantí, Spain.

More challenges? More solutions.

“This transaction will bring additional value to our customers, further reinforcing EW Nutrition’s global market position, and increasing its product portfolio and geographical reach,” says Michael Gerrits, Managing Director of EW Nutrition. “The products acquired will further support EW Nutrition’s mission to mitigate the impact of antimicrobial resistance by providing comprehensive animal nutrition solutions.”

Dan Meagher, President and CEO of Novus International, Inc., explained that the sale is part of Novus’s Project Destiny, a multi-year plan to focus the company’s resources on core platforms and emerging technologies, with a focus on gut health.

“We are pleased to have found a committed owner for these platforms so that they may continue bringing value to the industry,” said Meagher. “This event is a significant milestone in our Project Destiny journey. Now that our Feed Quality and Pigments platforms are in good hands with EW Nutrition, we are excited to focus our energies on developing new, innovative technologies into meaningful nutrition solutions for our customers.”

A robust services agreement between the companies is governing critical activities to ensure customers are supported through the transition.

The range of products is immediately available to our customers. You can find out more details on our Products page or by going directly to the relevant web page.

EW Nutrition launches new xylanase enzyme in Malaysia

Singapore – December 28, 2020 – In its continued efforts to reduce antibiotic use in the region while also improving farm profitability, EW Nutrition launched Axxess® XY in Malaysia on December 17, 2020.

Axxess® XY is a next-generation intrinsically thermostable xylanase, with unparalleled stability under high temperatures and especially longer conditioning time. With its ability to break down both the soluble and insoluble fiber fraction from feed ingredients, the enzyme offers high flexibility in feed formulation. The newly launched product thus gives feed producers peace of mind when working with various feed processing conditions, as well as significant feed cost savings.

The launch took place in the context of a customer online event titled “Revolutions in Poultry Nutrition: The Future of Enzymes” for customers in Malaysia. During the information-laden event, Dr. Howard Simmins, an accomplished global communicator and independent key opinion leader, highlighted the need for improved functionality from xylanases. With his vast experience on feed additive development for animal nutrition and health, including cutting edge biotech research into enzymes, probiotics, prebiotics and novel additives, Dr. Simmins also discussed ways to formulate feed accurately to optimize xylanase value, and optimize nutrition with enzyme products.

During the event, other presentations were delivered by Daniel Tepe, Managing Director, Dr. Andreas Michels, Head of Biotechnology, and Dr. Ajay Awati, Global Category Manager Gut Health and Nutrition, EW Nutrition. The webinar was hosted by Jurek Grapentin, Regional Director, EW Nutrition South East Asia/Pacific.

The webinar was rounded off with an interactive Question and Answer session, where the audience had the opportunity to have their questions answered live by the panel of speakers.

“This revolutionary enzyme is a testament of our dedication to provide a holistic suite of animal nutrition solutions to our valued customers in this region. Axxess® XY will provide a competitive edge with regard to feed formulation, which translates to cost savings to our customer. With the expertise of our R&D researchers, we are constantly striving to bring more innovative solutions to meet the challenging needs of this industry,” said Jurek Grapentin.

EW Nutrition Opens New Production Plant in China

Press Release

EW Nutrition Opens New Production Plant in China

On 29 October, German-based company EW Nutrition will officially open its new production plant in China. The new plant is the next step in the successful development of EWN Biotechnology Shanghai.

By offering holistic, science-backed solutions, EW Nutrition supports the Chinese industry in its effort to reduce antibiotic use. “With this latest investment,” says Craige Allen, General Manager, EWN Biotechnology Shanghai, “we are offering a twofold benefit to our Chinese customers: bringing our high-value products closer to the end-user, while implementing our policy of supporting antibiotic-free production in China.”

The new facility in Haimen will produce the three leading product lines in the company’s portfolio. They represent EW Nutrition’s answer to gut and respiratory health issues, as well as toxin risk management. “We are pleased to bring our programs closer to our customers, further increasing service levels,” says Michael Gerrits, Managing Director, EW Nutrition. “But we are even more pleased and honored to bring here our mission of mitigating the impact of antimicrobial resistance by providing comprehensive animal nutrition solutions.”

The virtual opening will take place at the Melia Hotel in Shanghai, to be followed by a one and a half-day symposium on “Reducing Antibiotic Use and Mitigating the AMR Risk – 2020 Vision”. Speakers include Prof. Chen Junshi, Prof. Jia Yanxiong, Prof. Suwit Chotinun, as well as other prestigious national and international guests.

About EW Nutrition

EWN Biotechnology Ltd. is the Chinese arm of EW Nutrition, an international animal nutrition company that offers integrators, feed producers, and self-mixing farmers comprehensive animal nutrition solutions for antibiotic reduction, young animal nutrition, toxin risk management and more.

Press contact
Caroline Gong
Marketing Manager, China
Email: caroline.gong@ew-nutrition.com
Phone: +86 021 6029 2278